BMEA Biomea Fusion, Inc.
Nasdaq · SEC CIK 1840439 · EDGAR
- Bought, last 12 months
- $196.4K 3 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 75 since 2021-08-05, latest 2026-06-12 16:15
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hitchcock Michael J.M. | Interim CEO, Dir | $99.0K | — |
| Erdtmann Rainer M | See Remarks, Dir | $97.4K | — |
Transactions 37
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-15 | 2025-12-11 | BMEA | Erdtmann Rainer M | See Remarks, Dir | P - Purchase | $1.43 | +30.0K | 723.0K | +4% | +$42.9K | |
| 2025-12-04 | 2025-12-02 | BMEA | Hitchcock Michael J.M. | Interim CEO, Dir | P - Purchase | $0.99 | +100.0K | 115.0K | +667% | +$99.0K | |
| M | 2025-12-02 | 2025-11-28+ | BMEA | Erdtmann Rainer M | See Remarks, Dir | P - Purchase | $1.09 | +50.0K | 683.0K | +8% | +$54.5K |
| DMI | 2025-08-13 | 2025-01-31 | BMEA | Erdtmann Rainer M | See Remarks, Dir | G - Gift | $0.00 | +30.0K | 19.4K | New | $0 |
| DM | 2025-08-13 | 2025-01-28+ | BMEA | Erdtmann Rainer M | See Remarks, Dir | G - Gift | $0.00 | -70.0K | 643.0K | -10% | $0 |
| 2024-12-02 | 2024-11-30 | BMEA | Valle Franco | CFO | A - Grant | $6.15 | +495 | 43.0K | +1% | +$3,044 | |
| 2024-10-01 | 2024-09-30 | BMEA | Hitchcock Michael J.M. | Dir | P - Purchase | $10.06 | +10.0K | 15.0K | +200% | +$100.6K | |
| 2024-06-12 | 2024-05-31 | BMEA | Frias Juan Pablo | Chief Medical Off | A - Grant | $8.94 | +349 | 349 | New | +$3,120 | |
| 2024-06-12 | 2024-05-31 | BMEA | Valle Franco | CFO | A - Grant | $3.78 | +4,448 | 30.0K | +17% | +$16.8K | |
| 2024-06-12 | 2024-06-11 | BMEA | Valle Franco | CFO | P - Purchase | $4.43 | +12.5K | 42.5K | +42% | +$55.4K | |
| M | 2024-01-03 | 2023-12-29 | BMEA | Erdtmann Rainer M | Pres, COO, Dir | G - Gift | $0.00 | -21.0K | 728.0K | -3% | $0 |
| MI | 2024-01-03 | 2023-12-29 | BMEA | Erdtmann Rainer M | Pres, COO, Dir | G - Gift | $0.00 | +9,000 | 10.0K | +900% | $0 |
| 2023-12-01 | 2023-11-30 | BMEA | Valle Franco | CFO | A - Grant | $3.78 | +1,345 | 25.5K | +6% | +$5,084 | |
| 2023-06-02 | 2023-05-31 | BMEA | Valle Franco | CFO | A - Grant | $3.78 | +4,273 | 24.2K | +21% | +$16.2K | |
| M | 2023-06-02 | 2023-05-31+ | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.11 | -125.0K | 3.55M | -3% | -$4.26M |
| 2023-05-17 | 2023-05-12 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $33.84 | -25.0K | 3.62M | -0.7% | -$846.0K | |
| M | 2023-05-10 | 2023-05-08+ | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.30 | -250.0K | 3.65M | -6% | -$8.57M |
| 2023-04-26 | 2023-04-20 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $29.12 | -200.0K | 3.90M | -5% | -$5.82M | |
| A | 2023-04-06 | 2023-03-31 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $31.25 | -200.0K | 4.10M | -5% | -$6.25M |
| 2023-04-06 | 2023-03-31 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $31.25 | +200.0K | 4.10M | +5% | +$6.25M | |
| I | 2023-04-03 | 2023-03-30 | BMEA | Cormorant Global Healthcare Master Fund, LP | 10% | P - Purchase | $30.00 | +400.0K | 3.57M | +13% | +$12.00M |
| MAI | 2023-02-10 | 2021-04-15 | BMEA | Erdtmann Rainer M | Pres, COO, Dir, 10% | P - Purchase | $17.00 | +8,400 | 3,000 | New | +$142.8K |
| 2022-12-02 | 2022-11-30 | BMEA | Valle Franco | CFO | A - Grant | $3.78 | +2,518 | 19.9K | +14% | +$9,518 | |
| 2022-11-16 | 2022-11-14 | BMEA | Hitchcock Michael J.M. | Dir | P - Purchase | $7.93 | +5,000 | 5,000 | New | +$39.6K | |
| 2022-11-14 | 2022-11-11 | BMEA | Valle Franco | CFO | P - Purchase | $7.63 | +4,100 | 17.4K | +31% | +$31.3K | |
| 2022-08-19 | 2022-08-16 | BMEA | A2A Pharmaceuticals, Inc. | 10% | P - Purchase | $13.87 | -30.7K | 4.30M | -0.7% | -$425.6K | |
| 2022-07-25 | 2022-07-21 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $11.21 | -34.7K | 4.33M | -0.8% | -$388.5K | |
| 2022-06-28 | 2022-06-24 | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $11.76 | -34.7K | 4.37M | -0.8% | -$407.6K | |
| I | 2022-06-03 | 2022-06-01 | BMEA | Biomea Health, LLC | 10% | J - Other | $0.00 | -4.37M | 0 | -100% | $0 |
| 2022-06-01 | 2022-05-31 | BMEA | Valle Franco | CFO | A - Grant | $4.67 | +3,307 | 13.3K | +33% | +$15.4K | |
| 2022-01-18 | 2022-01-14 | BMEA | Valle Franco | CFO | P - Purchase | $8.68 | +10.0K | 10.0K | New | +$86.8K | |
| 2021-09-21 | 2021-09-17 | BMEA | A2A Pharmaceuticals, Inc. | 10% | P - Purchase | $10.96 | +34.7K | 4.40M | +0.8% | +$379.9K | |
| I | 2021-09-21 | 2021-09-17 | BMEA | Stergiopoulos Sotirios | Dir | P - Purchase | $10.96 | +34.7K | 4.40M | +0.8% | +$379.9K |
| I | 2021-08-25 | 2021-08-23 | BMEA | Erdtmann Rainer M | Pres, COO, Dir, 10% | P - Purchase | $13.20 | +24.0K | 228.5K | +12% | +$316.8K |
| I | 2021-08-25 | 2021-08-23 | BMEA | Butler Thomas Andrew | CEO, Dir, 10% | P - Purchase | $13.20 | +24.0K | 228.5K | +12% | +$316.8K |
| MI | 2021-08-19 | 2021-04-15+ | BMEA | Butler Thomas Andrew | CEO, Dir, 10% | P - Purchase | $16.15 | +204.5K | 204.5K | New | +$3.30M |
| MI | 2021-08-19 | 2021-04-15+ | BMEA | Erdtmann Rainer M | Pres, COO, Dir, 10% | P - Purchase | $16.15 | +204.5K | 204.5K | New | +$3.30M |
Purchase Sale Sale after option exercise All abbreviations